middle.news
Island begins Galidesivir production for Ebola treatment program
9:41am on Friday 2nd of October, 2026 AEST
•
Biotechnology and pharmaceuticals
Read Story
Island begins Galidesivir production for Ebola treatment program
9:41am on Friday 2nd of October, 2026 AEST
Key Points
First 5kg GMP batch targeted for completion by end-October 2026
Supply earmarked for investigational use under the WHO MEURI framework
Second 5kg batch targeted for completion by late November
Prospective clinical and virological data may be collected in treated Ebola patients
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Island Pharmaceuticals (ASX:ILA)
OPEN ARTICLE